amoxapine has been researched along with Schizotypal Personality Disorder in 2 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
Schizotypal Personality Disorder: A personality disorder in which there are oddities of thought (magical thinking, paranoid ideation, suspiciousness), perception (illusions, depersonalization), speech (digressive, vague, overelaborate), and behavior (inappropriate affect in social interactions, frequently social isolation) that are not severe enough to characterize schizophrenia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "During a four-week open study, amoxapine (AX), a new antidepressant agent, was administered to seven patients with pseudoneurotic schizophrenia, seven with neurosis and another seven with schizophrenia, all having similar symptoms." | 9.05 | Effects of amoxapine, a new antidepressant, on pseudoneurotic schizophrenia. ( Aono, T; Kaneko, M; Kumashiro, H; Numata, Y; Takahashi, Y; Yamamoto, T, 1981) |
| "Five patients with borderline personality disorder (BPD) and 5 patients with schizotypal personality disorder (SPD) completed at least 3 weeks of treatment with amoxapine." | 5.06 | An open, noncomparative study of amoxapine in borderline disorders. ( Andersen, J; Jensen, HV, 1989) |
| "During a four-week open study, amoxapine (AX), a new antidepressant agent, was administered to seven patients with pseudoneurotic schizophrenia, seven with neurosis and another seven with schizophrenia, all having similar symptoms." | 5.05 | Effects of amoxapine, a new antidepressant, on pseudoneurotic schizophrenia. ( Aono, T; Kaneko, M; Kumashiro, H; Numata, Y; Takahashi, Y; Yamamoto, T, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aono, T | 1 |
| Kaneko, M | 1 |
| Numata, Y | 1 |
| Takahashi, Y | 1 |
| Yamamoto, T | 1 |
| Kumashiro, H | 1 |
| Jensen, HV | 1 |
| Andersen, J | 1 |
2 trials available for amoxapine and Schizotypal Personality Disorder
| Article | Year |
|---|---|
Effects of amoxapine, a new antidepressant, on pseudoneurotic schizophrenia.
Topics: Adult; Amoxapine; Clinical Trials as Topic; Dibenzoxazepines; Female; Humans; Male; Neurotic Disorde | 1981 |
An open, noncomparative study of amoxapine in borderline disorders.
Topics: Adult; Amoxapine; Borderline Personality Disorder; Clinical Trials as Topic; Dibenzoxazepines; Femal | 1989 |